Newsletters

The Regulation Digest
A weekly compendium of regulatory policy, news and analysis.


Photo of Roslyn Layton

"The Regulation Digest is better than an algorithm."

Dr. Roslyn Layton
Visiting Scholar, American Enterprise Institute


This Week's Edition

Features notable rulemaking activity by ED, FEMA, NOAA, CFTC, OCC, and FTC.

With opinions and analysis from Richard Williams, Gad Allon, Farhad Manjoo, James Broughel, William Galston, Chris Stirewalt, Sarah Fortt, Binyamin Appelbaum, Sambhav Sankar, Jarrett Skorup, Jill Family, Matt Levine, Rosa Lastra, and others.

Plus news from New York Times, Associated Press, Wall Street Journal, Washington Post, The Hill, Axios, E News, and Bloomberg.

 

 

 

 

 

 

 


"I recommend everyone subscribe to the Regulation Digest. It's really indispensable."

Adam White
Executive Director, Center for the Study of the Administrative State

Adam White headshot

Previous Editions of Regulation Digest

June 1, 2022

Full Newsletter

Features notable rulemaking activity from FDA, OFAC, HHS, EPA, and CFPB

With opinions and analysis from Howard Beales, Timothy Muris, Caroline Pham, Hester Peirce, Allysia Finley, Gerard Baker, Wayne Crews, Patrick Gleason, Reshma Ramachandran, Rachel Hammon, Jonathan Adler, and others.

Plus news from CNBCNew York TimesAssociated PressWall Street JournalThe HillPoliticoWashington Post, and Bloomberg.

May 25, 2022

Full Newsletter

Features notable rulemaking activity by FDA, ITA, NSF, OSTP, EPA, and President Biden.

With opinions and analysis from Zhoudan Xie, Bridget Dooling, Christopher Walker, James Broughel, Adam Thierer, Farhad Manjoo, William Galston, Scott Lincicome, Emily Ekins, Holman Jenkins, Joseph Antos, Ian Jefferies, Zeynep Tufekci, Roslyn Layton, Randy Barnett, Cass Sunstein, and others.

Plus news from New York TimesAssociated PressWall Street JournalE&E News, and Bloomberg.

May 18, 2022

Full Newsletter

Features notable rulemaking activity by NOAA, SEC, FCC, HUD, DHS, SEEB, and the Fed.

With opinions and analysis from Dylan Desjardins, Jonathan Adler, Scott Lincicome, William Galston, Tyler Cowen, Karen Kerrigan, Shuli Ren, Ya'ara Barnoon, Mazen Saleh, Stacey McKenna, Thomas Hazlett, Alden Abbott, Andrew Mercado, Elizabeth Nolan Brown, and others.

Plus news from ReutersNew York TimesAssociated PressWall Street JournalThe HillCNBCWashington Post, and Bloomberg.

May 11, 2022

Full Newsletter

Features rulemaking activity related to COVID-19 by HHS, CMS, HUD, and DOT. Plus other notable actions by FHWA, ISB, DOE, EPA, and HHS.

With opinions and analysis from Bjorn Lomborg, Rochelle Toplensky, Richard Morrison, Ross Douthat, Roger Ballentine, Sarah Wall, Paul Kupiec, Susan Ness, Chris Riley, Drew Kershen, Henry Miller, Daniel Takash, Robby Soave, Eugene Volokh, and others.

Plus news from New York TimesWall Street JournalThe HIllAssociated PressWashington PostLos Angeles TimesWashington Examiner, and Bloomberg.

May 4, 2022

Full Newsletter

Features rulemaking activity related to COVID-19 by HHS and FEMA. Plus other notable actions by NHTSA, FDA, FCC, DHS, EPA, and FERC.

With opinions and analysis from Adam Thierer, Gerard Baker, Harvey Pitt, Mairead McGuinness, Shane Tews, Patrick Hedger, Jared Schoreder, John Ruple, Jamie Pleune, Isaac Brown, Robert Martin, Henry Miller, Andrew Fillat, Kevin Williamson, Stephen Mihm, Bill Greenwalt, Dustin Walker, Brent Orrell, Matthew Mitchell, and others.

Plus news from ReutersNew York TimesAssociated PressWall Street JournalThe HillVoxWashington Post, and Bloomberg.

April 27/28, 2022

Full Newsletter

Features rulemaking activity related to COVID-19 by HHS, DHS, and GEO. Plus other notable actions by NTIA, NMFS, OPM, and President Biden.

With opinions and analysis from Steven Balla, Huang Chen, Yat To Yeung, Tyler Cowen, James Broughel, Travis Nix, Allysia Finley, Vivek Ramaswamy, Amrita Kulka, Caroline Cecot, James Taranto, Vasant Dhar, Jonathan Turley, William Dudley, Cary Coglianese, Alicia Lai, Anne Junod, Heidi Shierholz, Randy May, and others.

Plus news from ReutersNew York TimesAssociated PressWall Street JournalThe HillPoliticoWashington Post, and Bloomberg.

April 20, 2022

Full Newsletter

Features rulemaking activity related to COVID-19 by the CDC and FDA. Plus other notable actions by CEQ, FDA, SEC, and EPA.

With opinions and analysis from Richard Pierce, Allysia Finley, Binyamin Appelbaum, Devin Hartman, Hannah Druckenmiller, Paul Kupiec, Ilya Somin, Stephen Carter, Alison Somin, Patrick Gleason, Anne Finucane, Robert Litan, and others.

Plus news from AxiosThe HillNew York TimesGovernment ExecutiveWall Street JournalAssociated PressPolitico, and Bloomberg.

April 13, 2022

Full Newsletter

Features rulemaking activity related to COVID-19 by President Biden, CDC, and HHS. Plus other notable actions by SEC, DOE, CFPB, and HHS.

With opinions and analysis from Earl Baker, Peggy Noonan, Brian Blase, Crispin Sartwell, Peter Wallison, Andy Mukherjee, Elizabeth Rush, Pete Sepp, Howard Husock, Lindsey Stroud, Jamelle Bouie, Eli Lehrer, Yael Ossowski, and others.

Plus news from New York TimesWall Street JournalThe HillAssociated PressWashington PostCNBCReutersE&E News, and Bloomberg.

April 6, 2022

Full Newsletter

Features rulemaking activity related to COVID-19 by the CDC. Plus other notable actions by the FDIC, EPA, Interior, and OSTP.

With opinions and analysis from Steve Balla, Bridget Dooling, Emily Hammond, Dylan Desjardins, Phil Gramm, Christine Wilson, James Broughel, Jonathan Adler, Eric Bolinder, Jason De Sena Trennert, Michelle Dhansinghani, Eswar Prasad, Steve Forbes, and others.

Plus news from SalonNew York TimesWall Street JournalTimeE&E NewsAssociated PressWashington Post, and Bloomberg.

 

The Regulatory Studies Center Update

A monthly(ish) collection of working papers, events, op-eds and insights.
 

Subscribe to the Monthly Bulletin
 

Latest Edition

 

 

 

 

This update featured a Minnesota Law Review Article by Bridget Dooling and Laura Stanley: Extending Pandemic Flexibilities for Opioid Use Disorder Treatment.

Susan Dudley co-authored an op-ed with Sally Katzen for RealClear Policy, "Senators Working Across the Aisle for Better Regulation."

There are also insights by Zhoudan Xie on regulatory uncertainty, Daniel Pérez on a recent draft ACUS report to improve the Congressional Review Act, Bridget Dooling on the Benefits of Rowdy Bureacracy and the OSHA vaccine mandate, and Laura Stanley on interim-final rules. Plus commentaries by our graduate students Timberley Thompson and Dylan Desjardins on distributional language in executive orders and a new report by the OECD on agile regulation.

Previous Editions of the Regulatory Studies Center Update

 

July 2021

This update features a recent report by co-authored by Steve Balla and Bridget Dooling Mass, Computer-Generated, and Fraudulent Comments, for the Administrative Conference of the United States. Dooling and Balla also joined Susan Dudley on the GW Trachtenberg School's summer conversation series to discuss the report and more: Mass, Bots, and Fake Comments on Rulemaking.

The update also includes research by Tara Sinclair and Zhoudan Xie on Sentiment and Uncertainty about Regulation, Mark Febrizio and Kekai Liu on The Frequency of Regulatory Suspensions in the 21st Century, commentary on President Biden's executive order on competition, distributional effects in regulatory impact analysisequity in rulemakingagency guidance documents, and antitrust enforcement.

Also featured is Bridget Dooling's selection by the Administrative Conference of the United States to work with Rachel Potter from the University of Virginia to study the use of contractors in the rulemaking process.

Plus various op-eds in Slate and Forbes, events with the Regulatory Transparency Project, Case Western University, Women in Government Relations, Environmental Protection Agency, and the ABA's AdLaw Section. Plus quotes in popular media outlets, including the Los Angeles TimesThe Hill, and Yahoo.

May 2021

Full Newsletter

This update features our recent report by Bridget Dooling and Laura Stanley Unsupervised Use of Opioid Treatment Medications, which is the second part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project. It also includes a Congressional testimony by Howard Beales, and analysis of the Congressional Review Act by Daniel Pérez, President Biden's actions to undo Trump administration rulemaking by Mark Febrizio, and a report to the Administrative Conference of the United States by Steve Balla and Bridget Dooling.

Also featured is Bridget Dooling's appearance on the GovActually podcast with Princeton University professor Martha Coven to discuss being a part of the Biden Transition Team.

Plus various op-eds in the The Philadelphia Inquirer and Forbes, events with ABA AdLaw Section, Society for Benefit-Cost Analysis, Environmental Law Institute, Midwest Political Science Assocation, and the GW Economics Department, and quotes in popular media outlets, including The Wall Street Journal, NPR, Government Executive, Daily Beast, Marketplace, and Axios.

March 2021

Full Newsletter

This update features our recent report by Bridget Dooling and Laura Stanley Telemedicine & Initiating Buprenorphine Treatment, which is part of our Extending Pandemic Flexibilities for Opioid Use Disorder Treatment project. It also includes scholarly articles by Susan Dudley on President Biden's early executive actions, Jerry Ellig on surface freight deregulation, and Bridget Dooling on GAO's role in the administrative state and her innovative research on bespoke regulatory review.

There is also an analysis of regulatory sentiment by Zhoudan Xie, a reflection on the year that was 2020 by Mark Febrizioi and Zhoudan Xie, opioid treatment waivers by Laura Stanley, and advice for the Biden-Harris administration from Richard J. Pierce, Jr. and Susan Dudley.

Plus various op-eds in the Wall Street JournalThe HillForbes, and Government Executive, events with American Economic Association, Federalist Society, and Southern Economic Association, and quotes in popular media outlets, including the Wall Street JournalFederal News NetworkScienceBloombergUSA Today, and Axios.

November 2020

Full Newsletter

This update features our recent Delivering the Goods event with analysis from STB general counsel Craig Keats and UW-Milwaukee professor James Peoples, and includes scholarly articles by Bridget Dooling on the Administrative Procedure Act, Brian Mannix on the EPA's 50th anniversary, and Aryamala Prasad & Daniel Pérez on the effects of GDPR.

There is also an analysis of FCC spectrum auctions by Gerald Brock, and public interest comments related to immigration policies from DHS by Mark Febrizio, OPM's paid parental leave by Joseph Cordes & Jerry Ellig, and a Section 230 petition by Jerry Ellig.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the Wall Street JournalNew York TimesThe HillBloombergForbesPoliticoReutersAudubon MagazineGovernment Executive, and Law360.

August 2020

Full Newsletter

This update includes scholarly articles by Susan Dudley on the durability of OIRA's regulatory oversight, Bridget Dooling on a new concept for independent agency rulemaking called Bespoke Regulatory Review, Jerry Ellig on how to improve economic analysis at federal agencies, and Zhoudan Xie's review of regulations and news coverage during the COVID-19 pandemic.

There are also public interest comments on a recent EPA proposal by Brian Mannix and Joe Cordes, a review of the Spring Unified Agenda by Daniel Pérez, and Mark Febrizio provides a full analysis of the Trump Administration's regulatory budget.

Plus various commentaries, op-eds, and quotes in popular media outlets, including the New York Times, The Hill, Bloomberg, Forbes, Politifact, and Vox.